AFT Pharmaceuticals hits $200m revenue milestone despite profit dip

AFT Pharmaceuticals hits $200m revenue milestone despite profit dip
AFT co-founder Dr Hartley Atkinson says launching into new markets takes time to reap rewards. (Image: AFT Pharmaceuticals)
Rebecca Stevenson
AFT Pharmaceuticals' co-founder, Dr Hartley Atkinson, says the firm’s choice to invest in Australia has been vindicated. The dual-listed pharmaceutical company released its results for the year ended March 31 on Thursday. While profit after tax fell to $11.9 million, revenue cracked $200m for the first time. Revenue from Australia increased by 17% to $127.1m, and operating profit leapt 65% to $25.5m. Chief executive Atkinson said AFT's investment in Australia had caused some concern, but the result proved its strate...

More Markets

Property companies help boost NZ sharemarket
Markets Market Close

Property companies help boost NZ sharemarket

Ryman Healthcare, Argosy Property and Goodman all saw share-price rises.

Tom Raynel 05 Jun 2025
Genesis takes another step in increasing NZ's battery capacity
Markets

Genesis takes another step in increasing NZ's battery capacity

Grid-scale batteries add to the mix, but questions remain over economic viability.

Ian Llewellyn 05 Jun 2025
NZ sharemarket rises strongly on power company gains
Markets Market Close

NZ sharemarket rises strongly on power company gains

Positive day for Mercury and Meridian as well as a2 Milk despite gloom on global front. 

Tom Raynel 04 Jun 2025